Cited by 85Alzheimer's disease research and treatmentsBarrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

Cerebral clearance of human amyloid‐β peptide (1–40) across the blood–brain barrier is reduced by self‐aggregation and formation of low‐density lipoprotein receptor‐related protein‐1 ligand complexes

Open access
Ito, Shingo, Ohtsuki, Sumio, Kamiie, Junichi, Nezu, Yasuko, Terasaki, Tetsuya·2007·Journal of Neurochemistry

Abstract

Soluble amyloid‐β peptide (Aβ) exists in the form of monomers and oligomers, and as complexes with Aβ‐binding molecules, such as low‐density lipoprotein receptor‐related protein‐1 (LRP‐1) ligands. The present study investigated the effect of self‐aggregation and LRP‐1 ligands on the elimination of human Aβ(1–40) [hAβ(1–40)] from the rat brain across the blood–brain barrier. Incubation of [125 I]hAβ(1–40) monomer resulted in time‐dependent and temperature‐dependent dimer formation, and the apparent elimination rate of [125 I]hAβ(1–40) dimer was significantly decreased by 92.7% compared with that of [125 I]hAβ(1–40) monomer. Pre‐incubation with LRP‐1 ligands, such as activated α2‐macroglobulin (α2M), apolipoprotein E2 (apoE2), apoE3, apoE4, and lactoferrin, reduced the elimination of [125 I]hAβ(1–40). By contrast, pre‐administration of the same concentration of these molecules in the rat brain did not significantly inhibit [125 I]hAβ(1–40) monomer elimination. Purified [125 I]hAβ(1–40)/activated α2M complex and [125 I]activated α2M were not significantly eliminated from the rat brain up to 60 min. MEF‐1 cells, which have LRP‐1‐mediated endocytosis, exhibited uptake of [125 I]activated α2M, and enhancement of [125 I]hAβ(1–40) uptake upon pre‐incubation with apoE, suggesting that [125 I]activated α2M and [125 I]hAβ(1–40)/apoE complex function as LRP‐1 ligands. These findings indicate that dimerization and LRP‐1‐ligand complex formation prevent the elimination of hAβ(1–40) from the brain across the blood–brain barrier.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2007.04938.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Accumulating recent evidence strongly suggests that when human apoE is complexed with Aβ, the brain to blood clearance of Aβ is actually decreased compared to that of free Aβ.

    “Accumulating recent evidence strongly suggests that when human apoE is complexed with Aβ, the brain to blood clearance of Aβ is actually decreased compared to that of free Aβ (Bell et al., 2007; Deane et al., 2008; Ito et al., 2007).”

    From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Ito et al., 2007

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Ab clearance reduction by complex formation 2489 Ó 2007 The Authors Journal Compilation Ó 2007 International Society for Neurochemistry, J. Neurochem. (2007) 103, 2482-2490 14714159, 2007, 6, · DOI
  2. S. Ito et al. Journal Compilation Ó 2007 International Society for Neurochemistry, J. Neurochem. (2007) 103, 2482-2490
  3. Ó 2007 The Authors 14714159, 2007, 6, · DOI

Cited by

Sorted by citations

Authors
Ito, S., Ohtsuki, S., Kamiie, J., Nezu, Y., & Terasaki, T.
Affiliations
Tohoku University (JP)
Corresponding author
Terasaki, Tetsuya
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2007-08-30
Volume
103
Issue
6
Pages
2482-2490
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2064025889
Cited by
85
References
5
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 1 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 2 · 2013: 6 · 2012: 10
FWCI
3.59
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurochemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
Aβ(1-40), self-aggregation, dimerization, LRP1, alpha2-macroglobulin, apolipoprotein E, lactoferrin, endocytosis, amyloid-beta oligomers, Alzheimer's disease
MeSH terms
alpha-Macroglobulins, Alzheimer Disease, Animals, Apolipoproteins E, Blood-Brain Barrier, Cell Line, Cerebral Cortex, Endocytosis, Humans, Lactoferrin, Ligands, Male, Metabolic Clearance Rate, Peptide Fragments, Protein Binding, Amyloid beta-Peptides, Rats, Sprague-Dawley, Dimerization, Low Density Lipoprotein Receptor-Related Protein-1, Macromolecular Substances, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review